SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4%
Mon, 1 Feb

SUN PHARMA has announced its results for the quarter ended December 2020. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-19*
3
Sep-20*
3
Dec-20*
QoQ ChangeYoY Change
Net SalesRs m81,54985,53188,3683.3%8.4%
Other incomeRs m1,1992,5583,15023.1%162.7%
TurnoverRs m82,74788,08991,5173.9%10.6%
ExpensesRs m63,13563,59964,3061.1%1.9%
Gross profitRs m18,41421,93324,0619.7%30.7%
DepreciationRs m5,4704,9865,3196.7%-2.8%
InterestRs m630333261-21.6%-58.5%
Profit before taxRs m13,51319,17221,63112.8%60.1%
TaxRs m3,276-3122,449-25.2%
Profit after taxRs m10,23719,48419,181-1.6%87.4%
Gross profit margin%22.625.627.2
Effective tax rate%24.2-1.611.3
Net profit margin%12.422.121.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 8.4% on a year-on-year (YoY) basis. The expenses were up by 1.9% YoY during the same period.
  • The company's operating profit increased by 30.7% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.2% in 3QFY21 as against 22.6% in 3QFY20.
  • Depreciation charges declined by 2.8% and finance costs declined by 58.5% YoY, respectively.
  • Other income increased by 162.7% YoY during the quarter.
  • Net profit for the quarter increased by 87.4% YoY. Net profit margins during the quarter increased from 12.4% in 3QFY20 to 21.0% in 3QFY21.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 3.3% on a quarter-on-quarter (QoQ) basis. The expenses were up by 1.1% QoQ during the same period.
  • The company's operating profit increased by 9.7% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.2% in 3QFY21 as against 25.6% in 2QFY20.
  • Net profit for the quarter declined by 1.6% QoQ, while net profit margins declined from 22.1% in 2QFY20 to 21.0% in 3QFY21.

To see how SUN PHARMA has performed over the last eight quarters,please visit here.

JUST IN: Limited-Time Access to Full Transcript of Our Urgent Broadcast on India's Revival

SUN PHARMA Share Price Performance

Over the last one year, SUN PHARMA share price has moved up from Rs 422.6 to Rs 585.0, registering a Gain of Rs 162.4 or around 38.4%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 20,585.1 (down 0.2%). Over the last one year it has moved up from 13,734.3 to 20,585.1, a gain of 6,851 points (up 49.9%).

Overall, the S&P BSE SENSEX is up 18.5% over the year.

Current Valuations

At the current price of Rs 585.0, the price to earnings (P/E) ratio of SUN PHARMA stands at 72.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.1 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4%". Click here!

  

Related Views on News

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On...(Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Apr 16, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - ORCHID PHARMA COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS